Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., No. 24-2002 (Fed. Cir. Apr. 16, 2025)

Dismissed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 24-2002
Decided
April 16, 2025
Judge
See opinion
Document
Nonprecedential Opinion
Length
2 pages

NOTE: This order is nonprecedential. United States Court of Appeals

for the Federal Circuit REGENERON PHARMACEUTICALS, INC.,

Plaintiff-Appellee

v.

MYLAN PHARMACEUTICALS INC., BIOCON

BIOLOGICS INC.,

Defendants-Appellants

AMGEN USA, INC., CELLTRION, INC., SAMSUNG BIOEPIS CO., LTD., FORMYCON AG, AMGEN INC.,

Defendants

2024-2002

Appeal from the United States District Court for the Northern District of West Virginia in Nos. 1:22-cv-00061-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:24-cv-00053-TSK, 1:24-md-03103-TSK-JPM, Chief Judge Thomas S. Kleeh.

O R D E R

The parties, having so agreed, IT IS ORDERED THAT:

22 REGENERON PHARMACEUTICALS, INC. v. MYLAN

PHARMACEUTICALS INC. The above-captioned appeal is dismissed under Fed. R. App. P. 42(b) with each side to bear their own costs.

FOR THE COURT

Figure on page 2 of the opinion

April 16, 2025 Date

ISSUED AS A MANDATE: April 16, 2025

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., No. 24-2002 (Fed. Cir. Apr. 16, 2025).

Record ID
CAFC-24-2002-20250416
Permalink
https://patentcasewatch.com/opinions/CAFC-24-2002-20250416

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.